Cyril Amarchand Mangaldas Advised Healthcare Global Enterprises Limited On Its Rights Issue Of Equity Shares

Cyril Amarchand Mangaldas advised HCG on INR 424.68 crore rights issue listed on BSE and NSE.

Update: 2026-04-09 10:15 GMT


Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on its rights issue of equity shares

The leading law firm in India, Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on its rights issue of equity shares, April 09, 2026, Mumbai. The transaction, aggregating to approximately INR 42,468.18 lakhs, involved the issuance of equity shares which commenced trading on the BSE and NSE on April 1, 2026. The firm provided comprehensive legal counsel on all key aspects of the rights issue.

The Cyril Amarchand Mangaldas team was led by Yash Ashar (Senior Partner), Reuben Chacko (Partner, Regional Co-Head - Capital Markets - South) and Abhyuday Bhotika (Partner), with support from Surya Rajkumar (Associate), Bhaskar Kumar (Associate), Dhruv Sharma (Associate) and Megha Rajesh (Associate).

On specific arrangements concerning promoter participation in the rights issue, the team was led by Anand Jayachandran (Partner), supported by Astha Tambi (Principal Associate) and Arundhati Diljit (Associate).

Click to know more about Cyril Amarchand Mangaldas

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.


Tags:    

Similar News